The global biologics market size accounted for USD 487.00 billion in 2025 and is forecasted to hit around USD 1,144.20 billion by 2034, representing a solid CAGR of 9.96% from 2025 to 2034. The North America market size was estimated at USD 197.90 billion in 2024 and is expanding at a CAGR of 10.08% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biologics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biologics Market, by Source
8.1.1. Microbial
8.1.1.1. Market Revenue and Forecast
8.1.2. Mammalian
8.1.2.1. Market Revenue and Forecast
8.1.3. Others
8.1.3.1. Market Revenue and Forecast
9.1. Biologics Market, by Product
9.1.1. Monoclonal Antibodies
9.1.1.1. Market Revenue and Forecast
9.1.2. Vaccines
9.1.2.1. Market Revenue and Forecast
9.1.3. RecombinantProteins
9.1.3.1. Market Revenue and Forecast
9.1.4. Antisense, RNAi & molecular therapy
9.1.4.1. Market Revenue and Forecast
9.1.5. Cell Based Therapies
9.1.5.1. Market Revenue and Forecast
9.1.6. Others
9.1.6.1. Market Revenue and Forecast
10.1. Biologics Market, by Indication
10.1.1. Oncology
10.1.1.1. Market Revenue and Forecast
10.1.2. Immunological Disorders
10.1.2.1. Market Revenue and Forecast
10.1.3. Cardiovascular Disorders
10.1.3.1. Market Revenue and Forecast
10.1.4. Hematological Disorders
10.1.4.1. Market Revenue and Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Forecast
11.1. Biologics Market, by Manufacturing
11.1.1. Outsourced
11.1.1.1. Market Revenue and Forecast
11.1.2. In-house
11.1.2.1. Market Revenue and Forecast
12.1. Biologics Market, by Distribution Channel
12.1.1. Hospital Pharmacies
12.1.1.1. Market Revenue and Forecast
12.1.2. Retail Pharmacies
12.1.2.1. Market Revenue and Forecast
12.1.3. Online Pharmacies
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Source
13.1.2. Market Revenue and Forecast, by Product
13.1.3. Market Revenue and Forecast, by Indication
13.1.4. Market Revenue and Forecast, by Manufacturing
13.1.5. Market Revenue and Forecast, by Distribution Channel
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Source
13.1.6.2. Market Revenue and Forecast, by Product
13.1.6.3. Market Revenue and Forecast, by Indication
13.1.6.4. Market Revenue and Forecast, by Manufacturing
13.1.6.5. Market Revenue and Forecast, by Distribution Channel
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Source
13.1.7.2. Market Revenue and Forecast, by Product
13.1.7.3. Market Revenue and Forecast, by Indication
13.1.7.4. Market Revenue and Forecast, by Manufacturing
13.1.7.5. Market Revenue and Forecast, by Distribution Channel
13.2. Europe
13.2.1. Market Revenue and Forecast, by Source
13.2.2. Market Revenue and Forecast, by Product
13.2.3. Market Revenue and Forecast, by Indication
13.2.4. Market Revenue and Forecast, by Manufacturing
13.2.5. Market Revenue and Forecast, by Distribution Channel
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Source
13.2.6.2. Market Revenue and Forecast, by Product
13.2.6.3. Market Revenue and Forecast, by Indication
13.2.7. Market Revenue and Forecast, by Manufacturing
13.2.8. Market Revenue and Forecast, by Distribution Channel
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Source
13.2.9.2. Market Revenue and Forecast, by Product
13.2.9.3. Market Revenue and Forecast, by Indication
13.2.10. Market Revenue and Forecast, by Manufacturing
13.2.11. Market Revenue and Forecast, by Distribution Channel
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Source
13.2.12.2. Market Revenue and Forecast, by Product
13.2.12.3. Market Revenue and Forecast, by Indication
13.2.12.4. Market Revenue and Forecast, by Manufacturing
13.2.13. Market Revenue and Forecast, by Distribution Channel
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Source
13.2.14.2. Market Revenue and Forecast, by Product
13.2.14.3. Market Revenue and Forecast, by Indication
13.2.14.4. Market Revenue and Forecast, by Manufacturing
13.2.15. Market Revenue and Forecast, by Distribution Channel
13.3. APAC
13.3.1. Market Revenue and Forecast, by Source
13.3.2. Market Revenue and Forecast, by Product
13.3.3. Market Revenue and Forecast, by Indication
13.3.4. Market Revenue and Forecast, by Manufacturing
13.3.5. Market Revenue and Forecast, by Distribution Channel
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Source
13.3.6.2. Market Revenue and Forecast, by Product
13.3.6.3. Market Revenue and Forecast, by Indication
13.3.6.4. Market Revenue and Forecast, by Manufacturing
13.3.7. Market Revenue and Forecast, by Distribution Channel
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Source
13.3.8.2. Market Revenue and Forecast, by Product
13.3.8.3. Market Revenue and Forecast, by Indication
13.3.8.4. Market Revenue and Forecast, by Manufacturing
13.3.9. Market Revenue and Forecast, by Distribution Channel
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Source
13.3.10.2. Market Revenue and Forecast, by Product
13.3.10.3. Market Revenue and Forecast, by Indication
13.3.10.4. Market Revenue and Forecast, by Manufacturing
13.3.10.5. Market Revenue and Forecast, by Distribution Channel
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Source
13.3.11.2. Market Revenue and Forecast, by Product
13.3.11.3. Market Revenue and Forecast, by Indication
13.3.11.4. Market Revenue and Forecast, by Manufacturing
13.3.11.5. Market Revenue and Forecast, by Distribution Channel
13.4. MEA
13.4.1. Market Revenue and Forecast, by Source
13.4.2. Market Revenue and Forecast, by Product
13.4.3. Market Revenue and Forecast, by Indication
13.4.4. Market Revenue and Forecast, by Manufacturing
13.4.5. Market Revenue and Forecast, by Distribution Channel
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Source
13.4.6.2. Market Revenue and Forecast, by Product
13.4.6.3. Market Revenue and Forecast, by Indication
13.4.6.4. Market Revenue and Forecast, by Manufacturing
13.4.7. Market Revenue and Forecast, by Distribution Channel
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Source
13.4.8.2. Market Revenue and Forecast, by Product
13.4.8.3. Market Revenue and Forecast, by Indication
13.4.8.4. Market Revenue and Forecast, by Manufacturing
13.4.9. Market Revenue and Forecast, by Distribution Channel
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Source
13.4.10.2. Market Revenue and Forecast, by Product
13.4.10.3. Market Revenue and Forecast, by Indication
13.4.10.4. Market Revenue and Forecast, by Manufacturing
13.4.10.5. Market Revenue and Forecast, by Distribution Channel
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Source
13.4.11.2. Market Revenue and Forecast, by Product
13.4.11.3. Market Revenue and Forecast, by Indication
13.4.11.4. Market Revenue and Forecast, by Manufacturing
13.4.11.5. Market Revenue and Forecast, by Distribution Channel
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Source
13.5.2. Market Revenue and Forecast, by Product
13.5.3. Market Revenue and Forecast, by Indication
13.5.4. Market Revenue and Forecast, by Manufacturing
13.5.5. Market Revenue and Forecast, by Distribution Channel
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Source
13.5.6.2. Market Revenue and Forecast, by Product
13.5.6.3. Market Revenue and Forecast, by Indication
13.5.6.4. Market Revenue and Forecast, by Manufacturing
13.5.7. Market Revenue and Forecast, by Distribution Channel
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Source
13.5.8.2. Market Revenue and Forecast, by Product
13.5.8.3. Market Revenue and Forecast, by Indication
13.5.8.4. Market Revenue and Forecast, by Manufacturing
13.5.8.5. Market Revenue and Forecast, by Distribution Channel
14.1. Eli Lilly & Company
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Samsung Biologics
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. F Hoffman La Roche
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Celltrion Addgene
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Amgen
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbvie Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Sanofi
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Pfizer Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Merck & Co. Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Novo Nordisk A/S
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample